Dr. Leon Bernal-Mizrachi, MD

  • Advance, NC
  • Hematologist and oncologist
NPI1942336920PAC ID6901907781
Medicare services, 2024
98
Medicare patients, 2024
69
Part D claims, 2024
702
Publications
28
Clinical trials
2
Practice address
329 Nc Highway 801 N, Bermuda Run, NC 27006
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Davie Surgery - Ophthalmology - HOPD

Acute Care Hospital outpatient department · Bermuda Run, North Carolina

See all 6 affiliations

Find Dr. Bernal-Mizrachi's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Leon Bernal-Mizrachi is a hematologist and oncologist in Advance, North Carolina

Dr. Bernal-Mizrachi practices at Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina.

Dr. Bernal-Mizrachi's NPI, 1942336920, was assigned on February 26, 2007. Dr. Bernal-Mizrachi holds Georgia license 057283.

NPI and contact details
Medicare PAC ID
6901907781
NPI enumeration date
February 26, 2007
NPI status
Active
Accepts Medicare assignment
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
54
Medical school graduation
1998

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Leon Bernal-Mizrachi practices at Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina

Dr. Bernal-Mizrachi's primary practice is Davie Surgery - Ophthalmology - HOPD, at 329 Nc Highway 801 N, Bermuda Run, NC 27006.

  • Davie Surgery - Ophthalmology - HOPD
    329 Nc Highway 801 N, Bermuda Run, NC 27006

Source: Dmand AI Affiliation Data

Dr. Leon Bernal-Mizrachi is affiliated with 3 sites of care and 3 medical groups

Dr. Bernal-Mizrachi's primary practice is Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina. Dr. Bernal-Mizrachi is also affiliated with Atrium Health Wake Forest Baptist Medical Center. The medical group on file is Atrium Health Wake Forest Baptist. Dmand AI also links Dr. Bernal-Mizrachi to 1 more hospital and 2 medical groups, each named with a free account.

See all 6 affiliations for Dr. Bernal-Mizrachi

Source: Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Leon Bernal-Mizrachi's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bernal-Mizrachi practices, 3 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Davie Surgery - Ophthalmology - HOPDAvailable with a free account
+2 more sites and 2 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Bernal-Mizrachi practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Leon Bernal-Mizrachi is one of 420 hematologists and oncologists in North Carolina

Hematology and oncology is Dr. Bernal-Mizrachi's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Bernal-Mizrachi is licensed in Georgia.

Specialties and state licenses

  • Hematology and oncology, GeorgiaPrimaryLicense 057283 · taxonomy 207RH0003X

Hematologists and oncologists near Dr. Bernal-Mizrachi

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Leon Bernal-Mizrachi billed Medicare for 98 services in 2024

CMS data shows 98 Medicare services from Dr. Bernal-Mizrachi across 2 procedure codes in 2024, for 69 Medicare patients. Medicare paid $6,675 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 202498
Medicare patients69
Paid by Medicare$6,675
Procedure codes2

Dr. Bernal-Mizrachi's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 372024: 98165%

Dr. Bernal-Mizrachi compared with the North Carolina median for hematologists and oncologists, 2024

  • Dr. Bernal-Mizrachi
  • North Carolina median
Medicare services
98vs 45078% below
Medicare patients
69vs 18062% below
Part D claims
574vs 32477% above

Medians across 402 hematologists and oncologists in North Carolina with Dmand AI profiles that report each measure.

Dr. Bernal-Mizrachi's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Bernal-Mizrachi

Need commercial claims for Dr. Bernal-Mizrachi?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Bernal-Mizrachi and other hematologists and oncologists in North Carolina.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Leon Bernal-Mizrachi treated 69 Medicare patients in 2024, average age 68

CMS counts 69 Medicare patients who saw Dr. Bernal-Mizrachi in 2024. The largest group is 65 to 74, with 27 patients. 75% of them have high blood pressure, and 51% have high cholesterol. 58% are also on Medicaid. Their average risk score is 2.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bernal-Mizrachi's median patient age at 69, with 43% women.

Medicare patients, 202469
Average age68
Average risk score2.77
Also on Medicaid58%

Dr. Bernal-Mizrachi's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Bernal-Mizrachi's Medicare patients by sex, 2024

  • Women3855%
  • Men3145%

Chronic conditions among Dr. Bernal-Mizrachi's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol51%
  3. Chronic kidney disease48%
  4. Arthritis46%
  5. Diabetes33%
  6. Heart failure33%
  7. Ischemic heart disease29%
  8. Anxiety20%

Share of Medicare patients with each condition. A patient can have several.

Dr. Bernal-Mizrachi's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 69

Patient panel by sex, all payers

  • Women43%
  • Men57%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Leon Bernal-Mizrachi wrote 702 Medicare Part D claims in 2024

In 2024, Dr. Bernal-Mizrachi wrote 702 Medicare Part D claims for 65 patients. 75% of them were for generic drugs. CMS names the drug for 574 of them, across 16 drugs with 11 or more claims each, at $2,820,261 in total drug cost. In 2023, CMS named 673 claims across 14 drugs.

Part D claims, 2024702
Drugs named by CMS16
Total drug cost$2.8M
Part D patients65

Dr. Bernal-Mizrachi's Part D claims by kind of drug, 2024

  • Generic529 claims75%
  • Brand-name173 claims25%

Dr. Bernal-Mizrachi's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Bernal-Mizrachi's Part D claims, 2024

  • Opioids10%72 of 702 claims
  • Antibiotics3%19 of 702 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 6732024: 57415%

Drugs named by CMS: 16 in 2024, 14 in 2023.

See all prescribing by Dr. Bernal-Mizrachi

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Leon Bernal-Mizrachi scored 95 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Bernal-Mizrachi for performance year 2024, reported through an alternative payment model (APM). Dr. Bernal-Mizrachi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Bernal-Mizrachi's MIPS scores, performance year 2024

  • 95of 100Final score
  • 80.6of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Bernal-Mizrachi by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Leon Bernal-Mizrachi has 28 publications on record

Dmand AI links 28 papers to Dr. Bernal-Mizrachi, published from 2010 to 2024. 2015 was the busiest year, with 2. The most frequent topics are Lymphoma, Large B-Cell, Diffuse, Cell Line, Tumor and Antineoplastic Agents. Dr. Bernal-Mizrachi has published most often in Leuk Lymphoma. Dr. Bernal-Mizrachi's most frequent co-authors are Sagar Lonial, MD, Izidore Lossos, MD and Christopher Robert Flowers, MD.

Papers28
Years published2010 to 2024

Dr. Bernal-Mizrachi's papers by year, 2013 to 2024

Topics Dr. Bernal-Mizrachi writes about most

  • Lymphoma, Large B-Cell, Diffuse
  • Cell Line, Tumor
  • Antineoplastic Agents
  • Base Sequence
  • Antineoplastic Combined Chemotherapy Protocols
  • Molecular Sequence Data
  • Multiple Myeloma
  • Administration, Oral

Dr. Bernal-Mizrachi's most frequent co-authors

Recent publications by Dr. Bernal-Mizrachi

See all 28 publications and co-authors

See who Dr. Bernal-Mizrachi researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Bernal-Mizrachi works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Leon Bernal-Mizrachi has worked on 2 clinical trials

Dmand AI links Dr. Bernal-Mizrachi to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Deltaretrovirus Infections, Multiple Myeloma and Blood Protein Disorders.

Clinical trials with Dr. Bernal-Mizrachi by phase

  1. 1Phase 1: 1 trial
  2. NonePhase 2: no trials
  3. NonePhase 3: no trials
  4. 1Phase 4: 1 trial

Conditions in Dr. Bernal-Mizrachi's trials

  • Deltaretrovirus Infections
  • Multiple Myeloma
  • Blood Protein Disorders
  • HTLV-I Infections

Investigators on the most trials with Dr. Bernal-Mizrachi

Recent clinical trials with Dr. Bernal-Mizrachi

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Leon Bernal-Mizrachi received $94,415 in industry payments from 2016 to 2025

CMS Open Payments shows 86 general payments to Dr. Bernal-Mizrachi from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 58% of the total. Celgene Corporation paid the most, $36,677.

General payments to Dr. Bernal-Mizrachi by program year, 2016 to 2025

General payments to Dr. Bernal-Mizrachi by kind, 2016 to 2025

$94.4Kin total
  • Consulting fees$54,30258%
  • Speaker and faculty fees$27,00029%
  • Travel and lodging$11,13012%
  • Food and beverage$1,6832%
  • Education$3000%

Companies that paid Dr. Bernal-Mizrachi the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Bernal-Mizrachi

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Leon Bernal-Mizrachi's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Leon Bernal-Mizrachi

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Leon Bernal-Mizrachi's NPI number?

Dr. Leon Bernal-Mizrachi's NPI number is 1942336920. It was assigned on February 26, 2007, and it is active in the NPI Registry.

What kind of doctor is Dr. Leon Bernal-Mizrachi?

Dr. Leon Bernal-Mizrachi is a hematologist and oncologist in Advance, North Carolina. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Leon Bernal-Mizrachi practice?

Dr. Bernal-Mizrachi practices at 329 Nc Highway 801 N, Bermuda Run, NC 27006. Dr. Bernal-Mizrachi's primary practice is Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina. Dmand AI also links Dr. Bernal-Mizrachi to 1 hospital and 2 medical groups.

What is Dr. Leon Bernal-Mizrachi's medical license number?

Dr. Bernal-Mizrachi holds Georgia license 057283.

Which hospitals is Dr. Leon Bernal-Mizrachi affiliated with?

Dr. Bernal-Mizrachi is affiliated with Atrium Health Wake Forest Baptist Medical Center. Dmand AI links Dr. Bernal-Mizrachi to 1 more hospital.

What medical group is Dr. Leon Bernal-Mizrachi part of?

Dr. Bernal-Mizrachi is linked to Atrium Health Wake Forest Baptist. Dmand AI links Dr. Bernal-Mizrachi to 2 more medical groups.

Does Dr. Leon Bernal-Mizrachi accept Medicare?

Yes. CMS data shows Dr. Bernal-Mizrachi billed Medicare for 98 services in 2024, and Dr. Bernal-Mizrachi accepts Medicare assignment.

What is Dr. Leon Bernal-Mizrachi's MIPS score?

Dr. Bernal-Mizrachi's MIPS final score for performance year 2024 is 95 out of 100, reported through an alternative payment model (APM).

How many Medicare patients does Dr. Leon Bernal-Mizrachi see?

CMS counts 69 Medicare patients who saw Dr. Bernal-Mizrachi in 2024, with an average age of 68.

What services does Dr. Leon Bernal-Mizrachi bill to Medicare?

In 2024, Dr. Bernal-Mizrachi's most billed Medicare services were office visit, established patient (99214) and hospital inpatient care (99232).

Show 5 more questionsShow fewer questions

What drugs does Dr. Leon Bernal-Mizrachi prescribe most?

In 2024 Medicare Part D data, Dr. Bernal-Mizrachi's most prescribed drugs by claims were Acyclovir, Dexamethasone and Lenalidomide.

Has Dr. Leon Bernal-Mizrachi received payments from drug or device companies?

CMS Open Payments shows $94,415 in general payments to Dr. Bernal-Mizrachi from 9 companies from 2016 to 2025. The largest total came from Celgene Corporation.

How long has Dr. Leon Bernal-Mizrachi been practicing?

Dr. Bernal-Mizrachi graduated from medical school in 1998, 28 years ago.

Does Dr. Leon Bernal-Mizrachi do research?

Dmand AI links 28 publications to Dr. Bernal-Mizrachi, published from 2010 to 2024. Dr. Bernal-Mizrachi has worked on 2 clinical trials.

Who does Dr. Leon Bernal-Mizrachi publish with?

Dr. Bernal-Mizrachi's most frequent co-authors are Sagar Lonial, MD (5 shared papers), Izidore Lossos, MD (5 shared papers) and Christopher Robert Flowers, MD (4 shared papers).

Selling to hematology and oncology practices?

See hematologists and oncologists in North Carolina by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)